BSP PHARMACEUTICALS S.p.A

BSP PHARMACEUTICALS S.p.A

BS
0Products
1People
0Events
0Locations

Overview

Company details and contact information.

About

BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a specific focus on innovative compounds. With full containment facility, applying the most advanced and safe technologies, BSP can offer capabilities with a wide range of batch sizes providing flexibility to sustain preclinical, clinical and commercial manufacturing. The facility is designed to handle small molecules and large molecules, including ADCs (from Conjugation to Fill Finish), mAbs (including bi-specific), synthetic peptides, oligonucleotides, lipidic nanomedicine Production area includes: - a plant dedicated to Cytotoxic compounds, small and large molecules, (OEL <10ng/m3) with seven sterile manufacturing suites for injectable formulation (liquid and lyophilized); an oral department for solid formulation (tablets, capsules, Liquid filled hard gelatin capsules); BDS suites for liposomes and conjugation of ADCs. - a plant dedicated to non-Cytotoxic compounds, small and large molecules, (up to OEB 6) with seven sterile manufacturing suites for injectable formulation (liquid and lyophilized) Ancyllary areas to support manufacturing services for an integrated supply.include: - Development laboratories - QC laboratories (chemical, micro and bioanalytical) - Warehouse (storage @ RT, 2-8°C, -20°C, up to -85°C) The plant is approved by several regulatory authorities (including EMA, FDA, PDMA Japan, ANVISA Brazil) and produce for more than 80 Countries Worldwide BSP sets out to be a valuable point of reference to serve innovators involved in research on new generation therapies, applying the most advanced and safe technologies, in compliance with the highest Quality requirements. About BSP PHARMACEUTICALS S.p.A BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a strategic interest in specific therapeutic areas. In a campus of approximately 60 acres, with approximately 650,000 sqf built surface, the facility is designed to handle conventional small molecules, Biologics and ADCs (from Conjugation to Fill Finish) and very much focused on innovative compounds. With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements. BSP is positioned as a centre of excellence and a valued strategic partner among those small and large pharma and biotech companies with an advanced outsourcing process for strategic products with a high technological content.

Address
VIA APPIA KM 65.561, Latina Scalo Latina 04013, Italy

People

Contacts connected to this company.

GS

Giorgio Salciarini

Head of Sales - Technical Business Ddevelopment